Stay updated on PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial

Sign up to get notified when there's something new on the PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous v3.5.3. This indicates a new build of the page; the change affects only the version label and does not alter the study details or results.
    Difference
    0.1%
    Check dated 2026-05-16T09:25:08.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page’s interface revision indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T22:19:49.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T13:51:23.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T23:42:42.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:27:07.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is displayed, replacing the previous v3.4.1. This appears to be a backend/UI maintenance update with no visible changes to study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:25:20.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial page.